Literature DB >> 10719144

Neurobiological findings in early phase schizophrenia.

D Copolov1, D Velakoulis, P McGorry, A Yung, S Rees, G Jackson, A Rehn, W Brewer, C Pantelis.   

Abstract

This paper summarises the available information on MRI-determined hippocampal morphometry in first-episode patients as an illustration of the value and interpretation of findings in the neurobiology of early phase schizophrenia. We report a thin slice (1.5 mm) study of 32 first episode and 39 high risk patients which demonstrated significantly smaller hippocampi (right -9%, left -11%) in first episode patients that were of a similar magnitude to those found in chronic patients (right -10%, left -11%) but non-significant volume reductions in high risk individuals, including the 15 subjects who subsequently developed psychoses. Consideration is given to the implications of these findings, including the possible role of early and later neurodevelopmental influences. We present animal data showing that chronic placental insufficiency, as elicited by uterine artery ligation can give rise to substantial reduction (31%) in hippocampal volumes and reflect on other potentially relevant pathophysiological mechanisms, including those that may occur during the early phases of psychotic illnesses, including their prodromes. Greater attention needs to be paid to the study of early phase psychosis in order to obtain a clearer understanding of the nature and time course of neurobiological changes associated with it. Although there is a growing literature on first episode psychosis, there is a striking dearth of information on the neurobiology of the prodrome.

Entities:  

Mesh:

Year:  2000        PMID: 10719144     DOI: 10.1016/s0165-0173(99)00033-8

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  8 in total

1.  Recent approaches to psychological interventions for people at risk of psychosis.

Authors:  Andreas Bechdolf; Lisa J Phillips; Shona M Francey; Steven Leicester; Anthony P Morrison; Verena Veith; Joachim Klosterkötter; Patrick D McGorry
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-04       Impact factor: 5.270

2.  Could stress cause psychosis in individuals vulnerable to schizophrenia?

Authors:  Cheryl Corcoran; Lilianne Mujica-Parodi; Scott Yale; David Leitman; Dolores Malaspina
Journal:  CNS Spectr       Date:  2002-01       Impact factor: 3.790

3.  Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis.

Authors:  M Aas; P Dazzan; V Mondelli; T Toulopoulou; A Reichenberg; M Di Forti; H L Fisher; R Handley; N Hepgul; T Marques; A Miorelli; H Taylor; M Russo; B Wiffen; A Papadopoulos; K J Aitchison; C Morgan; R M Murray; C M Pariante
Journal:  Psychol Med       Date:  2010-06-09       Impact factor: 7.723

Review 4.  Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.

Authors:  Nasra Haroun; Laura Dunn; Ansar Haroun; Kristin S Cadenhead
Journal:  Schizophr Bull       Date:  2005-10-05       Impact factor: 9.306

Review 5.  [Correlations between risk gene variants for schizophrenia and brain structure anomalies].

Authors:  T Nickl-Jockschat; M Rietschel; T Kircher
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

Review 6.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

Review 7.  Limbic structures and networks in children and adolescents with schizophrenia.

Authors:  Tonya White; Kathryn Cullen; Lisa Michelle Rohrer; Canan Karatekin; Monica Luciana; Marcus Schmidt; Donaya Hongwanishkul; Sanjiv Kumra; S Charles Schulz; Kelvin O Lim
Journal:  Schizophr Bull       Date:  2007-10-17       Impact factor: 9.306

Review 8.  Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk.

Authors:  Stephen J Wood; Christos Pantelis; Dennis Velakoulis; Murat Yücel; Alex Fornito; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.